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Summary
The Ryan White Comprehensive AIDS Resources Emergency (CARE) Act
makes federal funds available to metropolitan areas and states to assist in health care
costs and support services for individuals and families affected by  the human
immunodeficiency virus (HIV) or acquired immune deficiency syndrome (AIDS).
P.L. 106-345, signed into law in October 2000, reauthorized the act through FY2005.
In July 2005, the Bush Administration released its reauthorization principles and an
outline of proposed changes to CARE Act programs.  Legislation  reauthorizing the
Ryan White CARE Act is expected to be introduced during the 109th Congress.
CARE Act programs received $2.038 billion in FY2006; the request for FY2007 is
$2.133 billion, a $95 million increase: $70 million for state grants under Title II and
$25 million for Title III grants.  This report will be updated periodically.
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AIDS:  The Ryan White CARE Act
Background
The Ryan White Comprehensive AIDS Resources Emergency (CARE) Act
makes federal funds available to metropolitan areas and states to provide a number
of health care services for AIDS patients including medical care, drug treatments,
dental care,  home health care, and outpatient mental health and substance abuse
treatment. The act is administered by the Health Resources and Services
Administration (HRSA) of the Department of Health and Human Services (HHS).
The act is commonly identified by its legislative Titles I, II, III, and IV.  It was
enacted as Title XXVI of the Public Health Service (PHS) Act and codified as Parts
A, B, C, D, E, and F under 42 U.S.C. § 300ff-111.  Funding for the individual titles
appears at the end of the report.
Title I/Part A — Emergency Relief Grant Program.  Title I provides
funds to eligible metropolitan areas (EMAs) with a population of at least 500,000
that have had more than 2,000 reported AIDS cases in the prior five years.  Services
supported by Title I grants include community-based outpatient medical and dental
care, rehabilitative services, home health and hospice care, transportation and
housing assistance, nutrition services, and respite care.  The program is intended to
assist low-income or under-insured people living with HIV.  A portion of each grant
must be spent on services for women, infants and children with HIV disease.  In
FY1991, the first year Title I grants were awarded, 16 EMAs were identified; by
FY2002, the number of EMAs had increased to the current total of 51.1
About half of the Title I appropriation is distributed through formula grants, and
the remaining half is distributed via discretionary supplemental grants awarded on
the basis of need.  Currently, formula grants are distributed to EMAs in proportion
to the estimated number of living AIDS cases in each EMA.  The number of living
AIDS cases is estimated from the number of reported AIDS cases over a 10-year
period with weighting factors to reflect that not all reported cases are still alive.
Under the 2000 reauthorization (P.L. 106-345), statistics on HIV cases, rather than
only on AIDS cases, would be used in the formula for determining Title I grant
amounts as early as FY2005 — if the Secretary of HHS finds the HIV incidence data
are sufficiently accurate and reliable.  In June 2004, the Secretary determined that
HIV case reporting is incomplete and cannot be used to distribute CARE Act grants.
Under P.L. 106-345, however, cases of HIV disease will be used for determining
FY2007 Title I grant amounts.
The hold harmless provision in Title I added in 1996 and changed in 2000 by
P.L. 106-345 resulted in some EMAs receiving lower funding.  Under the hold
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harmless provision in P.L. 106-345, an EMA cannot receive less than a percentage
of the Title I formula grant it received in a base year, protecting grantees from large
decreases in funding.  The base year can be different for each EMA.  For an EMA
facing a reduction in its formula grant, the base year is the year before the reduction.
In the first year after the base year, the EMA cannot receive less than 98% of what
it received in a base year.  By the fifth year, an EMA cannot receive a formula grant
that is less than approximately 87% of what it received in the base year if HIV
incidence data are included in the distribution formula, or 85% of what an EMA
received in the base year if HIV incidence data are not used in the fifth year.  The
hold harmless provision no longer applies when an EMA’s grant through the formula
is equal to or exceeds its hold harmless amount.  The hold harmless provision is
funded with money that would have been distributed through Title I supplemental
grants.
Title I grants are made to the chief elected official of the city or county in the
EMA that administers the health agency providing services to the greatest number of
persons with HIV.  The official must establish an HIV Health Services Planning
Council, which sets priorities for care delivery according to federal guidelines.  The
Council may not be directly involved in the administration of any Title I grant.
Membership of the Council must reflect the ethnic and racial make-up of the local
HIV epidemic.
Title II/Part B — Care Grant Program.  Title II awards formula grants to
states and territories for home and community-based health care and support services.
Services must be accessible to low-income individuals.  Many states use Title II
funds to provide services directly or through subcontracts with HIV care consortia.
Consortia are associations of public and nonprofit health care and support service
providers that assess needs and deliver services to individuals with HIV.  Title II
grants are also used to provide  (1) health insurance coverage for low-income persons
through Health Insurance Continuation Programs; and, (2) drug treatments under the
AIDS Drug Assistance Programs (ADAPs) for individuals with HIV who have
limited or no coverage from private insurance or Medicaid.2
The basic Title II grants are awarded based on a formula that takes into account
two factors:  (1) each state’s proportion of the estimated number of  living AIDS
cases (both inside and outside of Title I EMAs); and (2) each state’s proportion of the
estimated number of  living AIDS cases in the state who are not in a Title I EMA.
The first factor is given a greater weight (.80) relative to the second factor (.20) when
determining the Title II grant amount.  Estimated cases of people living with AIDS
in EMAs are included in both the allocation formula for Title I and for Title II.  As
a result, states with EMAs receive a larger amount of money, per case, than states
without an EMA.3
Under P.L. 106-345, statistics on  HIV cases rather than AIDS cases would be
used in the formula for determining Title II grant amounts by FY2005, but only if the
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Secretary of HHS determines that the HIV incidence data are sufficiently accurate
and reliable.  In June 2004, the Secretary determined that HIV case reporting is
incomplete and cannot be used to distribute CARE Act grants.  Starting in FY2007,
cases of HIV disease are to be used for determining Title II grants.
Two provisions can increase the basic Title II grant amount a state or territory
receives above what it would receive as a result of the formula alone.  A minimum
grant provision dictates that no state shall receive less than $200,000 if it has less
than 90 estimated living cases of AIDS or $500,000 if it has more than 90 estimated
living cases of AIDS.  A hold harmless provision dictates that a state shall not receive
a grant that is less than a specified percentage of what it received in FY2000.  These
two provisions are funded by reducing the grant amounts received by all states and
territories that do not receive a minimum grant amount or hold harmless grant
amount.  States with more than 1% of the total AIDS cases reported nationally must
contribute state matching funds based on a formula.  Grants may not be made to any
state that does not make a good faith effort to notify a spouse of an HIV-infected
patient that the spouse should seek testing.  States must use a portion of each Title
II grant on services for women, infants and children with AIDS.
P.L. 106-345 created a supplemental grant for states with metropolitan areas  in
which 500 to 1,999 cases of AIDS have been reported in the five most recent
calendar years.  These areas do not qualify for Title I funding.  Approximately 0.1%
of Title II funds are distributed among these “emerging communities.”  Half of the
money is distributed among emerging communities with between 500 and 999
reported cases, and half is distributed among emerging communities with 1,000 to
1,999 reported cases.  The grant is based on each area’s proportion of the total
number of cases in all eligible areas.
P.L. 106-345 changed the way funds would be allocated to states for the AIDS
Drug Assistance Programs (ADAPs).  Prior to P.L. 106-345, ADAP funds were
distributed among states based on each state’s proportion of AIDS cases.  Under P.L.
106-345, a new grant program distributes 3% of ADAP funds to states that
demonstrate a severe need to increase the availability of drugs.  Criteria for awarding
these grants are developed by the Secretary, taking into account eligibility standards,
formulary composition, and the number of HIV-positive individuals not receiving
drugs who are at or below 200% of the federal poverty level.  The remaining 97% of
ADAP funds are distributed based on each state’s proportion of AIDS cases.  Many
states have implemented cost containment measures, such as waiting lists, due to
insufficient ADAP funds.  On June 23, 2004, the Bush Administration announced a
$20 million initiative for 10 states with ADAP waiting lists (Alabama, Alaska,
Colorado, Idaho, Iowa, Kentucky, Montana, North Carolina, South Dakota, and West
Virginia); funding is expected to run out in March 2006.  According to the National
Alliance of State and Territorial AIDS Directors, as of January 18, 2006, 954
individuals were on ADAP waiting lists in ten states; 118 of these individuals are
receiving medications through the $20 million initiative.4
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Title III/Part C — Early Intervention Services.  Title III provides early
intervention  grants to public and private nonprofit entities already providing primary
care services to low-income and medically underserved people at risk for HIV.  Title
III grants are awarded to community and migrant health centers, homeless programs,
local health departments, family planning programs, hemophilia diagnostic and
treatment centers and other nonprofit community-based programs.  Title III services
include HIV testing, risk reduction counseling, case management, outreach, medical
evaluation, transmission prevention, oral health, nutritional and mental health
services, and clinical care.
Title IV/Part D — General Provisions.  In its original enactment, Title IV
authorized a number of different HIV-related programs; only one was ever funded:
the pediatric demonstration grants.  In the CARE Act’s 1996 reauthorization, the
pediatric demonstration grant program was replaced with a program of grants for
coordinated services and access to research for women, infants, children, and youth.
The grants enhance access to and linkage with clinical research supported by the
National Institutes of Health (NIH), and are to be made in coordination with the NIH
activities.  The grants provide opportunities for women, infants, children, and youth
to be voluntary participants in research of potential clinical benefit to individuals
with HIV.  Such individuals are provided health care on an outpatient basis, case
management, referrals, transportation, child care, and other incidental services to
enable participation.
Part E.  Part E authorizes grants for emergency response employees and
establishes procedures for notifications of infectious diseases exposure; Part E has
never been funded.
Part F — Demonstration and Training.  Part F provides support for the
Special Projects of National Significance (SPNS) Program, the AIDS Dental
Reimbursement (ADR) Program and the AIDS Education and Training Centers
(AETCs).  The SPNS program awards grants to public and nonprofit private entities
for the development of innovative models of HIV/AIDS care, especially programs
that deliver care to minority and hard-to-reach populations.  Under current statute,
the SPNS program is to be funded, up to $25 million, from amounts appropriated for
Titles I, II, III, and IV.  However, beginning in FY2003, each Labor-HHS
Appropriation bill has provided $25 million for the SPNS program via a funding
mechanism known as the “PHS evaluation tap.”  The tap, authorized under section
241 of the PHS Act, transfers money among PHS agencies for particular activities
as specified by the appropriators.5  The ADR program reimburses dental schools for
their treatment of AIDS patients.  The AETC program provides training for health
providers in the prevention of perinatal HIV transmission and prevention and
treatment of opportunistic infections.  Both the dental and the AETC programs were
transferred legislatively from Title VII of the PHS Act.
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Reauthorization
The CARE Act was signed into law in 1990 (P.L. 101-511) and reauthorized
and amended in 1996 (P.L. 104-146) and 2000 (P.L. 106-345).  P.L. 106-345 retained
the basic structure of the Ryan White CARE Act but changed the formulas used to
distribute Title I and Title II grants.  Additional changes made by P.L. 106-345 to the
CARE program included the following:  (1) requirements are established for the
development of epidemiologic measures to identify HIV-infected individuals not
currently in care; (2) incentives are provided to states for HIV testing of pregnant
women and infants; (3) incentives are established for implementing a partner
notification program; (4) requirements are set for the development of quality
management programs; (5) requirements are established for the development of a
plan for the medical case management of HIV-positive prisoners who are released
from custody; (6) requirements are included regarding the development of rapid HIV
tests; (7) and additional grants are provided to metropolitan areas with between 500
and 1,999 reported cases of AIDS over the previous five-year period.
In P.L. 106-345, Congress asked that the Institute of Medicine (IOM) conduct
a study to assess whether current allocation strategies equitably and efficiently
distribute CARE Act funds to areas with the greatest need, and whether quality of
care can be refined and expanded.  IOM published the study, Measuring What
Matters, in 2004.6  IOM evaluated whether the HIV case data reported by the states
to the Centers for Disease Control and Prevention are sufficiently accurate and
reliable for inclusion in the Title I and II formula grants, and found that states are not
equally capable of providing high-quality HIV data.  IOM made three
recommendations based on this finding:  that HRSA continue to use estimated living
AIDS cases in the formulas for at least the next four years, that efforts to improve the
quality of HIV data continue, and that additional studies be conducted to examine the
comparability of HIV reporting data across states for the purpose of allocating
resources.  IOM also evaluated how effectively CARE Act programs provide funds
to areas of severe need.  Factors other than estimated living AIDS cases are used to
assess severity of need — HRSA has relied on a qualitative assessment process.
IOM recommended methods of incorporating a more quantitative measure of
resource needs within the grant application process.  Lastly, IOM evaluated the
efforts by HRSA and CARE Act grantees to incorporate improvements in the quality
of care received by HIV-infected individuals.  IOM found that, overall, HRSA and
the clinics and programs funded by the CARE Act are doing an admirable job of
defining, assessing and trying to improve the quality of patient care.  However, IOM
recommended additional steps to measure and improve  quality of care.
In July 2005, the Bush Administration released a set of five reauthorization
principles:  serve the neediest first, focus on life-extending services, increase
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prevention efforts, increase accountability, and increase flexibility.7  The
administration also made a number of specific proposals:  75% of CARE Act funds
should be spent on core medical services; a priority list of core HIV/AIDS
medications for federal funding should be developed; the hold harmless provisions
should be eliminated; double counting of HIV/AIDS cases between states and
metropolitan areas should be eliminated; and unallocated balances should revert to
the Secretary of HHS for redistribution to states with the greatest need.  Legislation
reauthorizing the Ryan White CARE Act is expected to be introduced during the
109th Congress.
Table 1.  Federal Funding for the Ryan White CARE Act
($ in millions)
Title I Title II
(ADAP)





FY1991 87.8 87.8  — 44.9 19.5 0 17.0  — 257.0
FY1992 121.6 107.6  — 48.7 19.3 0 16.9  — 314.1
FY1993 184.8 115.3  — 48.0 20.9 0 16.4  — 385.4
FY1994 325.5 183.9  — 48.0 22.0 0 16.4 7.0 602.8
FY1995 356.5 198.1  — 52.0 26.0 0 16.3 6.9 655.8
FY1996 391.7 260.8 (52) 57.0 29.0 0 12.0 6.9 757.4
FY1997 449.8 417.0 (167) 69.6 36.0 0 16.3 7.5 996.3
FY1998 464.7 542.8 (285.5) 76.2 40.8 0 17.2 7.8 1,150.2
FY1999 505.0 737.7 (461.0) 94.3 46.0 0 20.0 7.8 1,410.9
FY2000 546.3 823.8 (528.0) 138.4 50.0 0 26.6 8.0 1,594.6
FY2001 604.2 910.9 (589.0) 185.9 65.0 0 31.6 10.0 1,807.6
FY2002 619.4 977.2 (639.0) 193.8 71.0 0 35.3 13.5 1,910.2
FY2003* 618.7 1,053.4 (714.3) 198.4 73.6 0 35.6 13.4 1,993.0
FY2004* 615.0 1,085.9 (748.9) 197.2 73.1 0 35.3 13.3 2,019.9
FY2005* 610.1 1,121.8 (787.5) 195.6 72.5 0 35.1 13.2 2,048.3
FY2006** 604.0 1,120.5 (789.5) 193.6 71.8 0 34.7 13.1 2,037.7
FY2007
Request*** 604.0 1,190.5 (789.5) 218.6 71.8 0 34.7 13.1 2,132.7
Source:  FY2005 and FY2006 Conference amounts are found in the Conference Report for H.R. 3010
(H.Rept. 109-337).  FY2006 and FY2007 Request amounts found in the HRSA FY2007 Justification
document.  May not add due to rounding.
Note:  The total does not include $25 million for SPNS provided via the PHS program evaluation tap
(section 241 of the PHS Act).
 
**FY2006 amount includes the 1% rescission and does not include the $25 million for SPNS.
***FY2007 Request does not include $25 million for SPNS.
